These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2886354)

  • 1. Effects of acute thioridazine, metoclopramide and SCH 23390 on the basal activity of A9 and A10 dopamine cells.
    Hand TH; Kasser RJ; Wang RY
    Eur J Pharmacol; 1987 Jun; 137(2-3):251-5. PubMed ID: 2886354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of thioridazine, clozapine and metoclopramide on the induction of adrenomedullary enzymes by apomorphine.
    Ekker M; Sourkes TL
    Neuropharmacology; 1985 Nov; 24(11):1063-6. PubMed ID: 2867484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390.
    Goldstein JM; Litwin LC
    Eur J Pharmacol; 1988 Oct; 155(1-2):175-80. PubMed ID: 2907487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat.
    Piontek JA; Wang RY
    Life Sci; 1986 Aug; 39(7):651-8. PubMed ID: 2874468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
    Hand TH; Hu XT; Wang RY
    Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.
    Nielsen EB; Jepsen SA
    Eur J Pharmacol; 1985 May; 111(2):167-76. PubMed ID: 2862045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioridazine chronic administration: a behavioural and autoradiographic study.
    Calzà L; Giardino L; Piazza PV; Amato G
    Neurosci Lett; 1990 Feb; 109(1-2):206-11. PubMed ID: 2314636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry.
    Lane RF; Blaha CD
    Brain Res; 1987 Apr; 408(1-2):317-20. PubMed ID: 2439169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
    Stockton ME; Rasmussen K
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):50-6. PubMed ID: 8935800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depolarization inactivation of dopamine neurons: an artifact?
    Mereu G; Lilliu V; Vargiu P; Muntoni AL; Diana M; Gessa GL
    J Neurosci; 1995 Feb; 15(2):1144-9. PubMed ID: 7869090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.
    Freeman AS; Bunney BS
    Brain Res; 1987 Mar; 405(1):46-55. PubMed ID: 3032350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.
    White FJ; Wang RY
    Science; 1983 Sep; 221(4615):1054-7. PubMed ID: 6136093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic thioridazine treatment differently affects DA receptors in striatum and in mesolimbo-cortical systems.
    Piazza PV; Calzà L; Giardino L; Amato G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):937-42. PubMed ID: 2345767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Life Sci; 1983 Feb; 32(9):983-93. PubMed ID: 6827927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.